Beta Drugs Limited (NSE:BETA)

Beta Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 6, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	17,060	19,235	11,861	6,027	5,437	1,038
Market Cap Growth	-1.80%	62.17%	96.79%	10.87%	423.79%	200.00%
Enterprise Value	17,292	19,147	11,782	6,023	5,446	1,127
Last Close Price	1690.00	1905.50	1175.00	597.10	538.57	114.29
PE Ratio	31.51	45.35	32.55	19.62	21.90	8.85
PS Ratio	4.37	5.31	4.01	2.65	2.96	0.89
PB Ratio	7.72	9.76	7.55	4.91	5.89	1.51
P/TBV Ratio	8.06	10.20	7.82	5.10	6.17	1.59
P/FCF Ratio	-	-	61.41	116.57	53.30	8.08
P/OCF Ratio	67.72	53.22	38.35	25.78	18.35	5.58
EV/Sales Ratio	4.43	5.28	3.98	2.65	2.96	0.97
EV/EBITDA Ratio	21.58	26.06	19.67	11.27	12.75	4.55
EV/EBIT Ratio	26.00	30.84	23.50	14.00	15.37	6.29
EV/FCF Ratio	-49.21	-	61.00	116.49	53.39	8.77
Debt / Equity Ratio	0.66	0.70	0.09	0.17	0.22	0.26
Debt / EBITDA Ratio	1.82	1.88	0.25	0.38	0.48	0.70
Debt / FCF Ratio	-	-	0.76	3.93	2.02	1.36
Asset Turnover	1.00	1.05	1.31	1.27	1.34	1.03
Inventory Turnover	3.65	3.88	4.51	4.88	5.83	5.09
Quick Ratio	2.12	2.54	1.42	1.43	1.42	1.45
Current Ratio	3.09	3.22	2.10	2.03	1.98	2.04
Return on Equity (ROE)	20.85%	23.95%	26.03%	28.54%	30.85%	18.65%
Return on Assets (ROA)	10.63%	11.24%	13.85%	15.10%	16.09%	9.97%
Return on Capital (ROIC)	14.67%	15.31%	19.89%	21.00%	22.26%	13.51%
Return on Capital Employed (ROCE)	17.80%	18.60%	29.60%	31.80%	32.60%	21.30%
Earnings Yield	2.46%	2.21%	3.07%	5.10%	4.57%	11.30%
FCF Yield	-2.06%	-0.04%	1.63%	0.86%	1.88%	12.38%
Buyback Yield / Dilution	22.61%	-5.00%	4.76%	-	-	-1.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.